Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Long-term Investments
Investments the company intends to hold for more than a year.
Sionna Therapeutics, Inc.NASDAQ: SION
Long-term Investments · Q1 FY2026 · quarter ended Mar 2026
Long-term investments falls 13.2% from a year ago
Long-term investments stood at $73.78M at the end of Q1 FY2026, down 13.2% from a year earlier and down 0.9% from the prior quarter.
Context
- Long-term investments amounted to 24.2% of total assets at the end of Q1 FY2026, up 1.2 pp from a year earlier.
- Long-term investments increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term investments keeps falling in the next quarterly balance sheet after a -13.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 74.42M USD
- Year-over-year change
- +262.9%
| Period | Period end | Long-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 74.42M | +262.9% |
| FY2024 | 2024-12-31 | 20.51M | +2031.5% |
| FY2023 | 2023-12-31 | 962K | — |
| FY2022 | 2022-12-31 | 0 | — |
Long-term Investments vs competitors
How SION compares with its peers on the latest reported figures
- SION's Mar 2026 long-term investments of $73.78M is the highest of the 11 companies compared; the peer median is $0.
- Its year-over-year change of -13.2% is the 3rd highest of 5, against a peer median of -17.0%.
- Long-term investments amounts to 24.2% of total assets for SION, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $73.78M | -13.2% | — | 24.2% | |
| Sep 2026 | $63.85M | -31.6% | -4.8% | 4.3% | |
| Mar 2026 | $10.56M | +869.3% | +146.5% | 2.5% | |
| Mar 2026 | $4.02M | -2.5% | — | 1.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | -100.0% | +261.3% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | +0.0% | 0.0% | |
| Peer median (excluding SION) | $0 | -17.0% | +73.2% | 0.0% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.